Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in Virology

Retrieve available abstracts of 40 articles:
HTML format
Text format



Single Articles


    November 2018
  1. MOHAMMADZADEH N, Follack TB, Love RP, Stewart K, et al
    Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies.
    Virology. 2018;527:21-31.
    PubMed     Text format     Abstract available


  2. LI H, Chen BK
    Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones.
    Virology. 2018;526:189-202.
    PubMed     Text format     Abstract available


    September 2018
  3. CONNOLLY S, Wall KM, Tang J, Yu T, et al
    Fc-gamma receptor IIA and IIIA variants in two African cohorts: Lack of consistent impact on heterosexual HIV acquisition, viral control, and disease progression.
    Virology. 2018;525:132-142.
    PubMed     Text format     Abstract available


  4. LIU Y, Guan X, Li C, Ni F, et al
    HSV-2 glycoprotein J promotes viral protein expression and virus spread.
    Virology. 2018;525:83-95.
    PubMed     Text format     Abstract available


    August 2018
  5. ZICARI S, Arakelyan A, Palomino RAN, Fitzgerald W, et al
    Human cytomegalovirus-infected cells release extracellular vesicles that carry viral surface proteins.
    Virology. 2018;524:97-105.
    PubMed     Text format     Abstract available


  6. GIULIANI E, Vassena L, Galardi S, Michienzi A, et al
    Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu.
    Virology. 2018;523:121-128.
    PubMed     Text format     Abstract available


  7. MEIER K, Jaguva Vasudevan AA, Zhang Z, Bahr A, et al
    Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV).
    Virology. 2018;523:52-63.
    PubMed     Text format     Abstract available


  8. NUNES JM, Furtado MN, de Morais Nunes ER, Sucupira MCA, et al
    Modulation of epigenetic factors during the early stages of HIV-1 infection in CD4(+) T cells in vitro.
    Virology. 2018;523:41-51.
    PubMed     Text format     Abstract available


    July 2018
  9. SELYUTINA A, Bulnes-Ramos A, Diaz-Griffero F
    Binding of host factors to stabilized HIV-1 capsid tubes.
    Virology. 2018;523:1-5.
    PubMed     Text format     Abstract available


  10. LIU H, Hu PW, Couturier J, Lewis DE, et al
    HIV-1 replication in CD4(+) T cells exploits the down-regulation of antiviral NEAT1 long non-coding RNAs following T cell activation.
    Virology. 2018;522:193-198.
    PubMed     Text format     Abstract available


  11. JAGUVA VASUDEVAN AA, Bahr A, Grothmann R, Singer A, et al
    MXB inhibits murine cytomegalovirus.
    Virology. 2018;522:158-167.
    PubMed     Text format     Abstract available


    June 2018
  12. GUO J, Liu X, Wu C, Hu J, et al
    The transmembrane nucleoporin Pom121 ensures efficient HIV-1 pre-integration complex nuclear import.
    Virology. 2018;521:169-174.
    PubMed     Text format     Abstract available


  13. BOWDER D, Hollingsead H, Durst K, Hu D, et al
    Contribution of the gp120 V3 loop to envelope glycoprotein trimer stability in primate immunodeficiency viruses.
    Virology. 2018;521:158-168.
    PubMed     Text format     Abstract available


  14. HONG F, Jacobs JL, Aga E, Cillo AR, et al
    Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy.
    Virology. 2018;521:51-57.
    PubMed     Text format     Abstract available


  15. TIMILSINA U, Ghimire D, Adhikari LP, Bhattarai A, et al
    Maturation inhibitors facilitate virus assembly and release of HIV-1 capsid P224 mutant.
    Virology. 2018;521:44-50.
    PubMed     Text format     Abstract available


    May 2018
  16. MEFFERD AL, Bogerd HP, Irwan ID, Cullen BR, et al
    Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR/Cas.
    Virology. 2018;520:116-126.
    PubMed     Text format     Abstract available


  17. MARSDEN MD, Wu X, Navab SM, Loy BA, et al
    Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.
    Virology. 2018;520:83-93.
    PubMed     Text format     Abstract available


  18. BOWDER D, Thompson J, Durst K, Hollingsead H, et al
    Characterization of twin-cysteine motif in the V2-loop region of gp120 in primate lentiviruses.
    Virology. 2018;519:180-189.
    PubMed     Text format     Abstract available


    April 2018
  19. BOLIAR S, Patil S, Shukla BN, Ghobbeh A, et al
    Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category.
    Virology. 2018;519:99-105.
    PubMed     Text format     Abstract available


    March 2018
  20. ZHANG Y, Lu J, Liu X
    MARCH2 is upregulated in HIV-1 infection and inhibits HIV-1 production through envelope protein translocation or degradation.
    Virology. 2018;518:293-300.
    PubMed     Text format     Abstract available


  21. BARKLIS E, Staubus AO, Mack A, Harper L, et al
    Lipid biosensor interactions with wild type and matrix deletion HIV-1 Gag proteins.
    Virology. 2018;518:264-271.
    PubMed     Text format     Abstract available


  22. MELTZER B, Dabbagh D, Guo J, Kashanchi F, et al
    Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.
    Virology. 2018;518:241-252.
    PubMed     Text format     Abstract available


    February 2018
  23. DEBOER J, Wojtkiewicz MS, Haverland N, Li Y, et al
    Proteomic profiling of HIV-infected T-cells by SWATH mass spectrometry.
    Virology. 2018;516:246-257.
    PubMed     Text format     Abstract available


  24. KHAN AS, Bodem J, Buseyne F, Gessain A, et al
    Spumaretroviruses: Updated taxonomy and nomenclature.
    Virology. 2018;516:158-164.
    PubMed     Text format     Abstract available


    January 2018
  25. SERTZNIG H, Hillebrand F, Erkelenz S, Schaal H, et al
    Behind the scenes of HIV-1 replication: Alternative splicing as the dependency factor on the quiet.
    Virology. 2018;516:176-188.
    PubMed     Text format     Abstract available


  26. ZHANG M, Robinson TO, Duverger A, Kutsch O, et al
    Regulatory CD4 T cells inhibit HIV-1 expression of other CD4 T cell subsets via interactions with cell surface regulatory proteins.
    Virology. 2018;516:21-29.
    PubMed     Text format     Abstract available


  27. CHUA BA, Ngo JA, Situ K, Ramirez CM, et al
    Protein S and Gas6 induce efferocytosis of HIV-1-infected cells.
    Virology. 2018;515:176-190.
    PubMed     Text format     Abstract available


    December 2017
  28. YASEN A, Herrera R, Rosbe K, Lien K, et al
    HIV internalization into oral and genital epithelial cells by endocytosis and macropinocytosis leads to viral sequestration in the vesicles.
    Virology. 2017;515:92-107.
    PubMed     Text format     Abstract available


  29. SCHULTE B, Selyutina A, Opp S, Herschhorn A, et al
    Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5.
    Virology. 2017;515:52-65.
    PubMed     Text format     Abstract available


  30. PREVOST J, Richard J, Ding S, Pacheco B, et al
    Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals.
    Virology. 2017;515:38-45.
    PubMed     Text format     Abstract available


    November 2017
  31. HOGAN MJ, Conde-Motter A, Jordan APO, Yang L, et al
    Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization.
    Virology. 2017;514:106-117.
    PubMed     Text format     Abstract available


  32. LIU Y, Chen J, Nikolaitchik OA, Desimmie BA, et al
    The roles of five conserved lentiviral RNA structures in HIV-1 replication.
    Virology. 2017;514:1-8.
    PubMed     Text format     Abstract available


    October 2017
  33. DIAZ F, Gregory S, Nakashima H, Viapiano MS, et al
    Intramuscular delivery of replication-defective herpes simplex virus gives antigen expression in muscle syncytia and improved protection against pathogenic HSV-2 strains.
    Virology. 2017;513:129-135.
    PubMed     Text format     Abstract available


  34. SCHWARTZ EJ, Vaidya NK, Dorman KS, Carpenter S, et al
    Dynamics of lentiviral infection in vivo in the absence of adaptive immune responses.
    Virology. 2017;513:108-113.
    PubMed     Text format     Abstract available


  35. MA TC, Le Guo, Zhou RH, Wang X, et al
    Soybean-derived Bowman-Birk inhibitor (BBI) blocks HIV entry into macrophages.
    Virology. 2017;513:91-97.
    PubMed     Text format     Abstract available


  36. DUFRASNE FE, Lucchetti M, Martin A, Andre E, et al
    Modulation of the NF-kappaB signaling pathway by the HIV-2 envelope glycoprotein and its incomplete BST-2 antagonism.
    Virology. 2017;513:11-16.
    PubMed     Text format     Abstract available


  37. YUE Y, Coskun AK, Jawanda N, Auer J, et al
    Differential interaction between human and murine Crm1 and lentiviral Rev proteins.
    Virology. 2017;513:1-10.
    PubMed     Text format     Abstract available


  38. JOSHI A, Cox EK, Sedano MJ, Punke EB, et al
    HIV-1 subtype CRF01_AE and B differ in utilization of low levels of CCR5, Maraviroc susceptibility and potential N-glycosylation sites.
    Virology. 2017;512:222-233.
    PubMed     Text format     Abstract available


    September 2017
  39. NAHABEDIAN J, Sharma A, Kaczmarek ME, Wilkerson GK, et al
    Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry.
    Virology. 2017;512:180-186.
    PubMed     Text format     Abstract available


  40. JIA M, Shaw T, Zhang X, Liu D, et al
    Decoding noises in HIV computational genotyping.
    Virology. 2017;511:249-255.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: